RIDA®Xplore Alliance
Exemplifying Our Design and
Manufacturing Capabilities
The RIDA®Xplore Alliance combines semi-automated nucleic acid extraction with Multiplex Tandem PCR (MT-PCR) technology to create a complete molecular diagnostic workflow for medium-throughput laboratories. By integrating the RIDA®Xtract 24 extraction system with the RIDA®Xplore platform, the Alliance streamlines sample processing, reduces manual handling and delivers reliable, reproducible results across a broad range of molecular diagnostic applications.
Features & Benefits
- Typical workflow time approximately 4.5 hours depending on assay configuration and sample throughput
- Separate sample purification and MT-PCR allows parallel batching
- Automatic sample aliquoting
- Automatic barcode scanning for reduced hands-on time
- Easy setup; takes just a few minutes
Integrated Workflow Automation
The RIDA®Xplore Alliance has been designed to simplify molecular diagnostic workflows by bringing semi-automated sample purification and multiplex PCR together in one integrated solution. The RIDA®Xtract 24 efficiently purifies nucleic acids from a wide range of specimen types before seamlessly feeding into the RIDA®Xplore platform for automated MT-PCR processing. This coordinated workflow reduces hands-on time, minimises opportunities for manual error and enables laboratories to maintain consistent performance while processing up to 24 samples per run.
RIDA®Xplore
The RIDA®Xplore system is an advanced Multiplex Tandem PCR (MT-PCR) platform designed to deliver rapid, sensitive and highly specific molecular detection across a wide range of clinical applications. By combining a streamlined workflow with the ability to detect multiple genetic targets in a single assay, RIDA®Xplore enables laboratories to improve diagnostic efficiency without compromising analytical performance. Its flexible throughput and intuitive operation make it well suited to laboratories seeking reliable molecular testing with consistent, reproducible results.
As part of the RIDA®Xplore Alliance, the platform integrates seamlessly with the RIDA®Xtract 24 system, creating an end-to-end workflow that minimises manual handling and supports efficient processing from purified nucleic acids through to final results. Together, these technologies provide a complete molecular diagnostic solution that enhances laboratory productivity while maintaining the accuracy and confidence expected from MT-PCR.
RIDA®Xtract 24
The RIDA®Xtract 24 system provides semi-automated nucleic acid extraction for laboratories requiring a dependable and flexible sample preparation solution. Using proven magnetic bead technology, it efficiently purifies DNA and RNA from a broad range of specimen types, producing high-quality nucleic acids suitable for downstream molecular applications. With the ability to process between one and 24 samples per run, the system adapts easily to changing laboratory workloads while delivering consistent extraction performance.
Within the RIDA®Xplore Alliance, the RIDA®Xtract 24 serves as the foundation of the molecular workflow, preparing purified nucleic acids that are transferred directly to the RIDA®Xplore platform for MT-PCR analysis. This integration reduces hands-on time, standardises sample preparation and helps laboratories maintain efficient, reproducible workflows from extraction through to molecular detection.
The Process
Advanced Multiplex PCR Technology
At the heart of the RIDA®Xplore Alliance is R-Biopharm’s Multiplex Tandem PCR (MT-PCR) technology, enabling the sensitive and specific detection of multiple genetic targets from a single sample. Combined with semi-automated nucleic acid extraction and intelligent workflow integration, the platform provides laboratories with a scalable molecular diagnostic solution that balances flexibility, accuracy and efficiency. Whether supporting routine syndromic testing or specialised molecular applications, the RIDA®Xplore Alliance delivers dependable performance with minimal hands-on intervention.
Complete Molecular Diagnostic Workflow
The RIDA®Xplore Alliance brings together advanced extraction technology, automated MT-PCR processing and intuitive workflow management to support modern molecular diagnostics. Designed for laboratories seeking reliable medium-throughput testing, the platform delivers a streamlined end-to-end solution that improves laboratory efficiency while maintaining the high levels of accuracy, consistency and traceability expected in today’s diagnostic environments. Supported by R-Biopharm Australia’s local expertise, the RIDA®Xplore Alliance helps laboratories perform molecular testing with confidence.
Systems are intended for in vitro diagnostics use by authorised clinical testing laboratories in Australia, New Zealand, Great Britain, and the European Economic Area, and are included on the Australian Register of Therapeutic Goods (ARTG), the MHRA database (REF: 10541) and compliant with the European Regulation (EU) 2017/746 . In the USA: For Research Use Only (RUO), not for use In diagnostic procedures.
